Deformity of spine

MANCHESTER, Conn., Feb. 29, 2024 /PRNewswire/ -- Woven Orthopedic Technologies, developer of Ogmend®, a simple implantable sleeve that quickly and easily secures stable screw fixation, has received its second 510(k) clearance from the Food and Drug Administration (FDA) for the use of Ogmend® Implant Enhancement System in spine surgery. "We are excited about this latest clearance of our Large-size Ogmend® because it provides surgeons with access to Ogmend® for a broader range of pedicle screw sizes, especially important for larger diameter screws used at the bottom of constructs, including the sacrum," said Brandon Bendes, CEO of Woven. Prominent industry groups and publications, including AO, the Journal of Neurosurgery, and the International Spine Study Group, have reported the complexities encountered in spinal surgeries, particularly in the lower lumbar and sacral segments. These areas are commonly stabilized with larger diameter screws given their larger bone structure and the greater forces endured. The resulting stresses placed on these screws can create challenges for surgeons that call for the use of special techniques and tools. "The large Ogmend® provides surgeons with a unique and simple tool for a number of situations where larger size screws are more common, such as longer construct corrections, complex thoracolumbar revisions, and complex spinal deformities," says Woven's Commercial Director, Justin Loosvelt. The Ogmend® LARGE joins the currently available Ogmend® MEDIUM to provide surgeons with a simple, off-the-shelf solution that ensures they are always prepared to quickly & easily secure stable fixation with screws ranging from 3.5mm – 10.5mm in diameter. The Ogmend® Implant Enhancement System is the first interface enhancement device that efficiently secures the entire screw/bone interface and provides multidimensional fixation enhancement by counteracting peak focal stress, facilitating bone growth, and increasing resistance to foundational failure. Both sizes of Ogmend® are now available in the United States and Europe. For further details regarding Ogmend® or to inquire about obtaining it for your institution, please visit or reach out to us via email at [email protected]. About Woven Orthopedic Technologies Woven Orthopedic Technologies is a commercial stage medical device company focused on making neuromusculoskeletal treatments easier, better, and more affordable for surgeons and global health systems. The company is based in Connecticut, USA. SOURCE Woven Orthopedic Technologies LLC

Funding from Hansjörg Wyss now totals $10 million, aiding the clinical care of children with spinal disorders and bolstering revolutionary research, naming the Center in perpetuity PHILADELPHIA, Feb. 22, 2024 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) is thrilled to announce a gift of $5 million from the Wyss Foundation to support innovations that improve the lives of patients with thoracic insufficiency syndrome (TIS). An initial gift from Hansjörg Wyss, philanthropist and chairman of the Wyss Foundation, was made to CHOP in 2019 and honored the legacy of the late Dr. Robert Campbell, a world-renowned CHOP pediatric orthopaedic surgeon. Now, additional funding has renamed and established the Wyss/Campbell Center for Thoracic Insufficiency Syndrome, one of CHOP's frontier programs, a trailblazing group of initiatives pioneering new advances in children's health. The Wyss/Campbell Center for Thoracic Insufficiency Syndrome is the first multidisciplinary program of its kind and is one of the only programs in the country dedicated to finding the right answers for children living with this complex medical condition, which affects healthy breathing and lung growth. The philanthropic impact and progress made since the 2019 gift include: The innovation and development of new machine learning-based algorithms to create a "3D movie" of a patient's lung throughout its respiratory cycle, which allows the team to leverage useful data in understanding respiratory function, determining patient-specific treatments and response to possible orthopaedic intervention and a better understanding of respiratory function as the child's body and organs grow. Laboratory-based research for the testing of a variety of imaging methods and models that answer fundamental questions about chest wall and spinal deformities and help the team develop new devices to treat some of these deformities. Modification of the standard vertical expandable prosthetic titanium rib (VEPTR) distractor, the only FDA-approved device to treat children with thoracic insufficiency syndrome, that was originally created by Dr. Campbell in the late 1980s, providing the ability to adjust the amount of force surgeons use to expand the chest and lengthen the spine in the growing child, providing a more personalized treatment approach. Monthly multidisciplinary clinics, launched in April 2021, where patients can be seen by experts in orthopaedics, pulmonology and physical therapy including imaging studies and lung function tests. Ongoing cutting-edge research of expanding distraction force technology, spinal tethering as an alternative to spinal fusion, measuring tether tension and illuminating growth modulation, all to provide more personalized methods of treating patients with thoracic insufficiency syndrome. "The generosity of Hansjörg Wyss and the Wyss Foundation is powering critical scientific advancements, fueling groundbreaking clinical research, and directly improving the healthcare of children, specifically those in under-resourced families," said Jack Flynn, MD, Chief of the Division of Orthopaedics and Richard M. Armstrong Jr. Endowed Chair in Pediatric Orthopaedic Surgery at CHOP. "This support is providing our clinicians with the vital platform for innovation to make tangible improvements in the lives of the patient families we serve. The progress we have made is possible because of this crucial backing and we are excited to reach new milestones in the years to come." The $5 million gift will ensure the Center, its clinical team, researchers and patients have the resources needed to thrive by amplifying studies, tools and education. The Center will be named Wyss/Campbell Center for Thoracic Insufficiency Syndrome in perpetuity. "CHOP is making vital contributions to pediatric health, enabling children to live longer, healthier lives. The Wyss Foundation is honored to support the team working to improve the quality of life for children living with TIS," said Molly McUsic, President of the Wyss Foundation. "The Wyss/Campbell Center is a great way to honor the legacy of Dr. Robert Campbell and is home to life-saving treatments and some of the world's most distinguished researchers and physicians." Learn more about the Wyss/Campbell Center for Thoracic Insufficiency Syndrome by visiting . About Children's Hospital of Philadelphia: A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey, as well as the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia. In addition, its unique family-centered care and public service programs have brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit . Contact: Kaitlyn Tivenan Children's Hospital of Philadelphia 610-618-0542 [email protected] SOURCE Children's Hospital of Philadelphia

KFAR SABA, Israel, Jan. 16, 2024 /PRNewswire/ -- Innovative medical technology company PathKeeper Surgical, headquartered in Israel, is reshaping the field of spinal surgery. The company is making significant strides to facilitate worldwide access to navigation-guided procedures for individuals grappling with spinal issues that require surgical intervention. Continue Reading PathKeeper Surgical Navigation system uses proprietary 3D camera and machine learning technology, to eliminate radiation in spinal surgical procedures. PathKeeper is being adopted in more US hospitals Renowned spine surgeons, Dr. Shirvinda "Shirvy" Wijesekera, MD, and Dr. Glenn Russo, MD, recently used the PathKeeper optical navigation system during spinal fusion surgeries at Midstate Medical Center in Meriden, CT, showcasing the system's capabilities. According to Dr. Shirvinda A. Wijesekera, MD, of Connecticut Orthopedics in Hamden, CT, "The PathKeeper system has an easy learning curve, impressive accuracy, and I believe there is significant value in optical navigation to reduce time and radiation in the operating room. I am excited to see how PathKeeper continues to develop their platform, especially for spinal deformity correction." The PathKeeper system replaces traditional navigation technology with a 3D optical, active camera. It is implant-agnostic and provides pinpoint tracking of patient anatomy and surgical instruments with reported registration and tool tracking accuracy of less than a millimeter. PathKeeper Surgical obtained FDA 510k clearance for the PathKeeper navigation system in 2023. The name "PathKeeper" encapsulates the essence of the system — a 3D optical navigation solution that 'keeps' the surgical 'path' on course throughout the surgery. Ryan LeBlanc, Chief Commercial Officer stated about PathKeeper, "We believe there are several unique value propositions that will be significant for the future of surgical navigation and robotics. Critical areas of improvement are a more efficient surgical workflow, elimination of radiation exposure during the surgical procedure, and a more economical price point so smaller hospitals, ambulatory-surgical centers, and emerging markets can incorporate this technology." Founded in 2018 by Erez Lampert, a 3D medical imaging expert, and with clinical guidance from Dr. Josh Schroeder, MD, PathKeeper Surgical is committed to addressing failure rates in spine surgeries. The company's proprietary camera and Artificial Intelligent software promises to surpass existing solutions in the field. Learn more at For media inquiries or additional information, please contact: Ryan LeBlanc, Chief Commercial Officer [email protected] SOURCE PathKeeper